Does Aucatzyl cause side effects such as fatigue or nausea?

Aucatzyl is a targeted drug used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). According to clinical trial data and real-world use feedback, while the drug exerts anti-tumor efficacy, it may also be accompanied by certain adverse reactions. Fatigue and nausea are two of the more common side effects.

First of all, fatigue is one of the discomforts that most patients may experience during treatment. This feeling of fatigue is often related to the drug's effects on the bone marrow, immune system, and energy metabolism in the body. Some patients will feel a significant decrease in physical strength in the first few cycles of treatment, but with the adjustment of the treatment plan or the intervention of supportive treatments, such as nutritional supplements and regular work and rest, most patients can gradually adapt to this feeling of fatigue.

Secondly, nausea is also one of the more common adverse reactions of Obetogenate. Some patients may experience mild to moderate nausea reactions within a short period of time after injection. This situation mostly occurs in the early stages of treatment and can usually be relieved by adjusting the medication time and using antiemetic drugs. A few patients will even have their symptoms naturally relieved after several treatments.
Although Obetollenza may cause fatigue or nausea, most of these side effects are controllable and reversible. Clinicians will closely monitor the patient's physical condition during treatment, promptly assess the severity of adverse reactions, and formulate corresponding supportive treatment plans based on the patient's specific conditions. For most patients, these side effects will not affect the continuation of the entire course of treatment.
Reference: https://www.drugs.com/